Αποτελέσματα Αναζήτησης
18 Μαΐ 2022 · Lobular carcinoma in situ (LCIS) is an abnormal condition in which cells form in the milk glands of the breast. It doesn't cause signs or symptoms, but it increases the risk of invasive breast cancer by 20 percent.
LCIS is a type of breast change that increases the risk of invasive breast cancer. Learn about the types, diagnosis, treatment and prevention of LCIS from the American Cancer Society.
18 Μαΐ 2022 · LCIS is a condition where abnormal cells are found in the breast, but not invasive cancer. Learn about the diagnosis, treatment and prevention options for LCIS, and how it differs from PLCIS.
Lobular carcinoma in situ (LCIS) is a microscopic finding of abnormal cells in the lobules of the breast, which may progress to invasive lobular carcinoma (ILC). Learn about the causes, diagnosis, morphology, and immunohistochemistry of LCIS and its relation to LN and ILC.
LCIS is a condition where abnormal cells are found in the lobules of the breast, but they have not spread beyond the wall. Learn about the types, diagnosis, treatment and risk factors of LCIS, and how it differs from DCIS and other breast changes.
Synopsis. LCIS is both a risk factor and a non-obligate precursor of breast carcinoma. The relative risk of invasive carcinoma after a diagnosis of classic LCIS is approximately 9-10 times that of the general population. LCIS and ILC share common copy number alterations and somatic mutations.
6 Οκτ 2020 · Lobular neoplasia (LN) is an atypical proliferation of small, dyscohesive epithelial cells within the terminal duct lobular unit (TDLU), with or without pagetoid extension and encompasses both...